MedReleaf

Aurora Cannabis Inc. (NYSE: ACB), announced Saturday that Chief Corporate Officer Cam Battley has resigned effective Dec. 20.  Battley joined Aurora’s team in 2016 and was promoted to CCO in 2018. In November, he was hired by MedReleaf Australia’s board, and the...

Lavvan announced the appointment of Neil Closner as its new chief executive officer on Thursday. Closner left his position as CEO of MedReleaf and will be joining Lavvan's team along with seven other members of MedReleaf’s leadership team, Lavvan said in a press release. Lavvan is a...

Canada-based Aurora Cannabis Inc (OTC: ACBFF) has applied to be listed on the New York Stock Exchange. Aurora Cannabis will begin trading on the NYSE effective Tuesday, Oct. 23. What To Know The company intends to list under the ticker symbol ACB, but it will continue to list on the Toronto Stock...

By Etan Vlessing Over the last two years, Canadian cannabis producer Aurora Cannabis (OTC: ACBFF) has become a $5-billion stock market darling thanks to a dizzying string of deals. But Mark Lakmaaker, vice president of investor relations at Edmonton-based Aurora, told the Benzinga Cannabis Capital...

MedReleaf Corp (TSE:LEAF), one of the major licensed cannabis producers in Canada, started trading on the TSX on Wednesday and its debut was far from pleasant. After opening at C$9.50 ($7.04), shares lost 22 percent, closing at C$7.40 ($5.48). According to Bloomberg data, this drop marked "the...